Loading...
Heidelberg Pharma AG
HPHA.DE•XETRA
Healthcare
Biotechnology
€4.15
€-0.23(-5.25%)
Heidelberg Pharma AG (HPHA.DE) Financial Performance & Income Statement Overview
Review Heidelberg Pharma AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-30.53%
↓ 30.53%
Operating Income Growth
-15.79%
↓ 15.79%
Net Income Growth
4.74%
↑ 4.74%
Operating Cash Flow Growth
12.13%
↑ 12.13%
Operating Margin
-373.97%
↓ 373.97%
Gross Margin
64.14%
↑ 64.14%
Net Profit Margin
-303.90%
↓ 303.90%
ROE
-62.67%
↓ 62.67%
ROIC
-54.24%
↓ 54.24%
Heidelberg Pharma AG (HPHA.DE) Income Statement & Financial Overview
Review Heidelberg Pharma AG's (HPHA.DE) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.27M | $1.60M | $1.19M | $2.79M |
Cost of Revenue | $267770.00 | $505777.00 | $141366.00 | $1.54M |
Gross Profit | $1.003M | $1.10M | $1.05M | $1.25M |
Gross Profit Ratio | $0.79 | $0.68 | $0.88 | $0.45 |
R&D Expenses | $6.61M | $6.19M | $5.07M | $5.51M |
SG&A Expenses | $1.38M | $1.79M | $1.75M | $1.52M |
Operating Expenses | $7.99M | $7.98M | $7.02M | $7.03M |
Total Costs & Expenses | -$8.26M | -$8.49M | $7.16M | $8.57M |
Interest Income | $181863.00 | $310577.00 | $372359.00 | $378597.00 |
Interest Expense | $1533.00 | $1093.00 | $1548.00 | $37269.00 |
Depreciation & Amortization | $223659.00 | $221787.00 | $214865.00 | $216873.00 |
EBITDA | -$5.71M | -$4.90M | -$5.38M | -$3.97M |
EBITDA Ratio | -$4.50 | -$3.06 | -$4.51 | -$1.42 |
Operating Income | -$6.99M | -$6.88M | -$5.96M | -$5.79M |
Operating Income Ratio | -$5.50 | -$4.30 | -$5.00 | -$2.08 |
Other Income/Expenses (Net) | $1.05M | $1.76M | $370809.00 | $341329.00 |
Income Before Tax | -$5.94M | -$5.12M | -$5.59M | -$4.22M |
Income Before Tax Ratio | -$4.67 | -$3.20 | -$4.69 | -$1.51 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | -$48931.00 |
Net Income | -$5.94M | -$5.12M | -$5.59M | -$4.17M |
Net Income Ratio | -$4.67 | -$3.20 | -$4.69 | -$1.50 |
EPS | -$0.13 | -$0.11 | -$0.12 | -$0.09 |
Diluted EPS | -$0.13 | -$0.11 | -$0.12 | -$0.09 |
Weighted Avg Shares Outstanding | $46.60M | $46.60M | $45.07M | $46.60M |
Weighted Avg Shares Outstanding (Diluted) | $46.60M | $46.60M | $45.07M | $46.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan